The choice of local destruction method of colorectal cancer liver metastases-Reference-Cited by-同舟云学术

The choice of local destruction method of colorectal cancer liver metastases

Published:2019-12-22 Issue:4 Volume:24 Page:30-36
ISSN:2408-9524
Container-title:Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery
language:
Short-container-title:Ann. hir. gepatol.

Author:

Chzhao A. V.¹^ORCID,Vishnevsky V. A.¹^ORCID,Ionkin D. A.¹^ORCID,Olifir A. A.¹^ORCID,Ayvazyan X. A.¹^ORCID,Kovalenko Yu. A.¹^ORCID,Zhavoronkova O. I.¹^ORCID,Stepanova Yu. A.¹^ORCID,Karelskaya N. A.¹^ORCID

Affiliation:

1. Vishnevsky National Medical Research Center of Surgery

Publisher

Annals of Surgical Hepatology

Subject

Gastroenterology,Hepatology,Surgery

Reference17 articles.

1. Cutsem E.V., Cervantes A., Adam R., Sobrero A., Van Krieken J.H., Aderka D., Aguilar E.A., Bardelli A., Benson A., Bodoky G., Ciardiello F., D’Hoore A., Diaz-Rubio E., Douillard J.-Y., Ducreux M., Falcone A., Grothey A., Gruenberger T., Haustermans K., Heinemann V., Hoff P., Köhne C.-H., Labianca R., Laurent-Puig P., Ma B., Maughan T., Muro K., Normanno N., sterlund P., Oyen W.J.G., Papamichael D., Pentheroudakis G., Pfeiffer P., Price T.J., Punt C., Ricke J., Roth A., Salazar R., Scheithauer W., Schmoll H.J., Tabernero J., Taïeb J., Tejpar S., Wasan H., Yoshino T., Zaanan A., Arnold D. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 2016; 27 (8): 1386–142. https://doi.org/10.1093/annonc/mdw235

2. Sorich M.J., Wiese M.D., Rowland A., Kichenadasse G., McKinnon R.A., Karapetis C.S. Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a metaanalysis of randomized, controlled trials. Ann. Oncol. 2015; 26 (1): 13–21. https://doi.org/0.1093/annonc/mdu378

3. Pietrantonio F., Petrelli F., Coinu A., Di Bartolomeo M., Borgonovo K., Maggi C., Cabiddu M., Iacovelli R., Bossi I., Lonati V., Ghilardi M., de Braud F., Barni S. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. Eur. J. Cancer. 2015; 51 (5): 587–594. https://doi.org/10.1016/j.ejca.2015.01.054

4. Weiser M.R., Jarnagin W.R., Saltz L.B. Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach? Oncology (WillistonPark). 2013; 27 (11): 1074–1078.

5. Adam R., De Gramont A., Figueras J., Guthrie A., Kokudo N., Kunstlinger F., Loyer E., Poston G., Rougier P., RubbiaBrandt L., Sobrero A., Tabernero J., Teh C., Van Cutsem E. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012; 17 (10): 1225–1239. https://doi.org/10.1634/theoncologist.2012-0121

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraoperative Ultrasound in Colorectal Liver Metastases;Journal of Experimental and Clinical Surgery;2023-07-23

2. Current trends and outcomes of surgical treatment of colorectal cancer with liver metastasis;Siberian journal of oncology;2022-10-30

3. Hepatocellular cancer. Current trends and the results in surgical treatment;Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery;2022-09-20